tyb
>is that the new one?
nice..good luck
VENUS91 USAF C-32A south from Burlington, VT where the AZAZ0909 US Army C-560 did a fly by earlier-it is nw to the nw after returning to JBA and out with a fly over of Long Island and then New York Stewart Airport
VV500 USMC G5 coming down the walk from a Ramstein AFB departure earlier
made this a bit ago
o7
Chilean AF FACH911 G4 appears off south Florida/Nassau Bahamas nw-this AC had two turn arounds just east of Richmond, VA in the last 48 hours after a Savannah, GA departure-and this flight also departed from Hilton Head Int'l
SAM847 USAF G5 west from JBA
VENUS35 USAF C-40B out of JBA with fly-overs at Niagra Falls Int'l Airport, Portsmouth, NH and now finished with a spell aover Atlantic City, NJ
CASTL57 ANG C-130 from New Castle County Airport has joined VENUS35 from Atlantic City, NJ
AZAZ0909 US Army C-560 in on descent at Rochester, NY
German AF GAF101 Airbus A400M sw from Bangor, ME
Evofem Biosciences, Inc. sold by Acacia Research Group: $29.32m-June 4
Evofem Biosciences Inc, formerly Neothetics, Inc., is a clinical-stage specialty biopharmaceutical company. The Company develops products to address unmet needs in women's sexual and reproductive health. The Company’s product Amphora, is a Multipurpose Vaginal pH Regulator (MVP-R) designed to regulate vaginal pH to within the normal range of 3.5 to 4.5 even in the presence of semen. This maintains an acidic environment which is inhospitable to sperm as well as certain viral and bacterial pathogens associated with sexually transmitted infections. Amphora is used to prevent urogenital chlamydia and gonorrhea in women. The Company is in the second Phase III clinical trial of Amphora for prevention of pregnancy (AMP002). The Company is currently designing a Phase IIb trial for its second product candidate, a MVP-R to reduce the recurrence of bacterial vaginosis. Number of employees : 53 people.
https://www.marketscreener.com/EVOFEM-BIOSCIENCES-INC-40267487/company/
Acacia Research Group
Acacia Research Corporation, founded in 1993, is an American company based in Irvine, California. Acacia partners with patent owners such as inventors and universities to license patents that are infringed. Roughly, 95% of the company's business involves licensing infringed patents on behalf of patent owners to some of the world's largest corporations through patent litigation. Acacia creates a subsidiary company that acts as a special purpose entity for each set of patents that it enforces. The patent owner assigns the infringed patents to the subsidiary and the subsidiary then licenses the patents to companies who are infringing. Acacia and the patent owner split any revenues generated from licensing the patents on a 50/50 basis. Since the year 2000, Acacia has generated $1.4 Billion in revenue from licensing patents and has paid out over $731 Million to inventors and other patent owners. The company has formed 233 known subsidiaries and has litigated 1,412 cases, four of which were not through a subsidiary.
Acacia has been referred to as a non-practicing entity because the company derives revenue from licenses and lawsuits rather than from building products.
https://en.wikipedia.org/wiki/Acacia_Research
Acacia Agrees to Acquire Portfolio of Life Science Assets for £223.9 million
https://acaciaresearch.com/prviewer/release_only/id/4346684
https://acaciaresearch.com/
https://www.finviz.com/insidertrading.ashx?oc=934549&tc=7&b=2